Chicago Equity Partners’s Amedisys AMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
$863K Hold
4,700
0.09% 310
2019
Q4
$785K Sell
4,700
-6,765
-59% -$1.01M 0.05% 524
2019
Q3
$1.5M Sell
11,465
-17,295
-60% -$2.25M 0.07% 391
2019
Q2
$3.49M Buy
28,760
+4,505
+19% +$535K 0.16% 184
2019
Q1
$2.99M Sell
24,255
-14,205
-37% -$1.78M 0.12% 242
2018
Q4
$4.5M Buy
38,460
+4,160
+12% +$490K 0.18% 151
2018
Q3
$4.29M Buy
34,300
+11,060
+48% +$1.22M 0.13% 225
2018
Q2
$1.99M Buy
+23,240
New +$1.71M 0.06% 383

Other funds holding AMED

Chicago Equity Partners's AMED Position: Q1 2020 in Review

Chicago Equity Partners held its Amedisys (AMED) position steady in Q1 2020 at 4,700 shares worth $863K. The position accounts for 0.09% of the portfolio, ranked #310.

Chicago Equity Partners first reported a position in AMED in Q2 2018 and has held it in 8 quarters since. The position peaked at $4.5M in Q4 2018. 332 funds tracked by Wall St. Rank hold AMED as of Q1 2020.

  • Chicago Equity Partners held 4,700 shares of Amedisys worth $863K as of Q1 2020.
  • Chicago Equity Partners left its Amedisys share count unchanged in Q1 2020.
  • Amedisys made up 0.09% of Chicago Equity Partners's portfolio in Q1 2020, its #310 holding.
  • Chicago Equity Partners first reported a position in Amedisys in Q2 2018 and has held it in 8 quarters since.
  • Chicago Equity Partners's Amedisys position peaked at $4.5M in Q4 2018.
  • 332 funds tracked by Wall St. Rank held Amedisys as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.